Abstract
Several recent studies indicate that the majority of families with five or fewer cases of breast cancer and no cases of ovarian cancer are not due to BRCA1 or BRCA2. It has been proposed that a further breast cancer susceptibility gene that may account for some of these families is located on chromosome 8p12-p22. We have identified 31 site-specific breast cancer families that have a greater than 80% posterior probability of being due to genes other than BRCA1 or BRCA2. These families have been examined for linkage to 8p12-p22 using markers flanking the putative location of the gene. The overall multi-point LOD score is strongly negative across the whole 44 cM. The individual multi-point LOD score is negative in 23 families and only exceeds 0.5 in a single family (with a multi-point LOD score of 1.22). The maximum heterogeneity LOD score was 0.03 at marker D8S136 with estimated proportion linked (α) of 3% (95% CI 0–30%). These data do not lend support to the hypothesis that chromosome 8p12-p22 harbours a familial breast cancer susceptibility gene.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Claus EB, Risch N and Thompson WD. . 1991 Am. J. Hum. Genet. 48: 232–242.
Easton DF, Bishop DT, Ford D, Crockford GP and the breast cancer linkage consortium. . 1993 Am. J. Hum. Genet. 52: 678–701.
Ford D, Easton DF, Stratton MR, Narod SA, Golgar D, Devilee P, Bishop D, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck T, Tonin P, Neuhausen S, Barkadottir R, Eyfjord J, Lynch H, Ponder B, Gayther S, Birch J, Lindblom A, Stoppa-Lyonnet D, Bignon Y, Borg A, Hamann U, Haites N, Scott R, Maugard C, Vasen H, Seitz S, Cannon-Albright L, Schofield A, Zelada-Hedman . and the breast cancer linkage consortium. 1998 Am. J. Hum. Genet. 62: 676–689.
Hakansson S, Johansson O, Johansson U, Sellberg G, Loman N, Gerdes AM and Holmberg E. . 1997 Am. J. Hum. Genet. 60: 1068–1078.
Imbert A, Chaffanet M, Essioux L, Noguchi T, Adelaide J, Kerangueven F, Le Paslier D, Bonaiti-Pellie C, Sobol H, Birnbaum D and Pebusque M. . 1996 Genomics 32: 29–38.
Kerangueven F, Essioux L, Dib A, Noguchi T, Allione F, Dib A, Noguchi T, Allione F, Geneix J, Longy M, Liderau, Eisinger F, Pebusque M, Jacquemier J, Bonaiti-Pellie C, Sobol H and Birnbaum D. . 1995 Oncogene 10: 1023–1026.
Kruglyak L, Daly MJ, Reeve-Daly MP and Lander ES. . 1996 Am. J. Hum. Genet. 58: 1347–1363.
Malone K, Dalin J, Thompson J, O'Brien C, Francisco L and Ostrander E. . 1998 JAMA 279: 922–929.
Miki Y, Swensen J, Shattuck Eidens D, Futreal PA, Harshman K, Tavtigian S, Lui Q, Chochran C, Bennett L, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow P, Norris F, Helvering L, Morrison P, Rosteck P, Lai M, Barrett J, Lewis C, Neuhausen S, Cannon-Allbright L, Goldgar D, Wiseman R, Kamb A and Skolnick M. . 1994 Science 266: 66–71.
O'Connell JR and Weeks DE. . 1995 Nat. Genet. 11: 402–408.
Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton D, Evans C, Deacon J and Stratton M. . 1999 J. Natl. Cancer Inst. 91: 943–949.
Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drusedau M, Hogervorst F, Hageman S, Arts P, Ligtenberg M, Meijers-Heijboer H, Klijn J, Vasen H, Cornelisse C, Veer L, Bakker E, Ommen G and Devilee P. . 1997 Nat. Genet. 17: 341–345.
Rahman N and Stratton MR. . 1998 Ann. Rev. Genet. 32: 95–121.
Schubert E, Lee M, Mefford H, Argonza R, Morrow J, Hull J, Dann J. . 1997 Am. J. Hum. Genet. 60: 1031–1040.
Seitz S, Rohde K, Bender E, Nothangel A, Kolble K, Schlag P and Scherneck S. . 1997a Oncogene 14: 741–743.
Seitz S, Rohde K, Bender E, Nothangel A, Pidde H, Ullrich O-M, El-Zehairy A, Haensch W, Jandrig B, Koble K, Schlag PM and Scherneck S. . 1997b Br. J. Cancer 76: 983–991.
Serova O, Mazoyer S, Puget N, Dubois V, Tonin P, Schugart Y, Goldgar D, Narod S, Lynch H and Lenoir G. . 1997 Am. J. Hum. Genet. 60: 486–495.
Spurr NK, Blanton S, Bookstein R, Clarke R, Cottingham R, Daiger S, Drayna D, Faber P, Horrigan S, Kas K, Kirchgessner C, Kumar S, Leach R, Luedecke H, Sim E, Sullivan L, Takle L, Vance J, Wagner M, Wells D, Westbrook C, Yaremko L, Zaletayev D, Zuffardi and Wood S. . 1995 Cytogenet. Cell Genet. 68: 148–155.
Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficence D, Kelsell D, Ford D, Tonin P, Bishop D, Spurr N, Ponder B, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Barkardottir R, Easton D, Bentley D, Futreal P, Ashworth A and Stratton MR. . 1995 Nature 378: 789–791.
Yaremko M, Recant W and Westbrook C. . 1995 Genes Chrom. Cancer 13: 186–191.
Yaremko M, Kutza C, Lyzak J, Mick R, Recant W and Westbrook C . 1996 Genes Chrom. Cancer 16: 189–195.
Acknowledgements
We are grateful to all the participating families. This research was supported by the Cancer Research Campaign, the Institute of Cancer Research, the Association for International Research (via grant MKHT 18 to D Goldgar) and the Medical Research Council (UK).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rahman, N., Teare, M., Seal, S. et al. Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22. Oncogene 19, 4170–4173 (2000). https://doi.org/10.1038/sj.onc.1203735
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203735
Keywords
This article is cited by
-
A pilot genome-wide association study of early-onset breast cancer
Breast Cancer Research and Treatment (2009)
-
Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families
Modern Pathology (2007)
-
BRCA1 and BRCA2 Mutations in Breast and Ovarian Cancer Syndrome: Reflection on the Creighton University Historical Series of High Risk Families
Familial Cancer (2006)
-
BAP1 and Breast Cancer Risk
Familial Cancer (2005)
-
BRCA1 and BRCA2: 1994 and beyond
Nature Reviews Cancer (2004)